CoheroHealth
Digital health company for respiratory patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$12.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
Cohero Health, established in 2013 by co-founders Melissa Manice and Daniel Weinstein, operates as a digital therapeutics company with a sharp focus on managing respiratory diseases, specifically asthma and Chronic Obstructive Pulmonary Disorder (COPD). The New York-based firm was developed to enhance respiratory care, minimize avoidable healthcare costs, and improve medication adherence through digital technology. In a significant milestone, the company was acquired by AptarGroup, a global leader in drug delivery solutions, which integrated Cohero Health's assets to expand its digital respiratory health capabilities.
The company's business model is centered on providing a comprehensive suite of digital tools to patients, healthcare providers, and pharmaceutical companies. Its revenue streams are derived from this B2B2P model, offering its platform and connected devices to pharmaceutical partners and healthcare systems to improve patient outcomes and gather critical data. This approach allows for better disease management by connecting patients and providers through real-time data and communication.
Cohero Health's core offering is a connected health platform that includes several integrated components. The HeroTracker® sensors are Bluetooth-enabled devices that attach to inhalers to automatically record medication usage. The platform also features portable spirometers (mSpirometer™ and cSpirometer™) for patients to measure their lung function wirelessly, with data sent directly to a smartphone app. This data is aggregated in the BreatheSmart® App, which provides patients with reminders, educational content, and tracks adherence and lung function. All information is securely stored on the BreatheSmart® Connect HIPAA-compliant cloud platform, enabling remote monitoring and care coordination for healthcare providers.
Keywords: respiratory care, digital therapeutics, asthma management, COPD management, medication adherence, remote patient monitoring, connected health, smart inhaler, digital health platform, spirometer, AptarGroup, respiratory disease, health technology, patient engagement, telehealth, mHealth, medical device, chronic care management, healthcare data